The application of biotechnology in drug discovery has been discovered to be a promising and resourceful approach for the discovery of novel therapeutic candidates that comes with less time and cost than the traditional ways of drug discovery. This has additionally endowed researchers with the necessary understanding of diseases, which offers exceptional methods for treating patients. Additionally, diagnosis and treatment are becoming increasingly intertwined with the help of biotechnology. Today, researchers in biotechnology deal with the root of diseases and find solutions through therapeutic agents, hence, improving quality of life. The discovery of drugs in recent days is practically challenging without good modeling in biotechnology, this wonderful technique is now being adopted in the discovery of new and effective classes of drugs which include but are not limited to gene therapy, cancer vaccines, proteins, and even enzymes. In this current review, we review the efforts so far in the usage of this approach in drug discovery. The review targets the biotechnological application and design implementation in drug discovery. It explains the use of proteins, genes, in-silico, and stem cells in designing models for enhanced drug discovery, the chemical similarity network for drug discovery, and future recommendations on the integration of AI in biotechnology.
Cite this paper
Suleiman, T. A. , Francis, A. C. , Ibrahim, A. , Jonn-Joy, A. O. , Adebiyi, E. and Anyimadu, D. T. (2023). Biotechnological Drug Development—The Role of Proteins, Genes, In-Silico, and Stem Cells in Designing Models for Enhanced Drug Discovery. Open Access Library Journal, 10, e520. doi: http://dx.doi.org/10.4236/oalib.1110520.
Trosset, J.Y. and Carbonell, P. (2015) Synthetic Biology for Pharmaceutical Drug Discovery. Drug Design, Development, and Therapy, 9, 6285-6302.
https://doi.org/10.2147/DDDT.S58049
Duelen, R., Corvelyn, M., Tortorella, I., Leonardi, L., Chai, Y.C. and Sampaolesi, M. (2019) Medicinal Biotechnology for Disease Modeling, Clinical Therapy, and Drug Discovery and Development. In: Matei, F. and Zirra, D., Eds., Introduction to Biotech Entrepreneurship: From Idea to Business, Springer, Berlin, 89-128.
https://doi.org/10.1007/978-3-030-22141-6_5
Ho, R.J. (2013) Biotechnology and Biopharmaceuticals: Transforming Proteins and Genes into Drugs. John Wiley & Sons, Hoboken.
https://doi.org/10.1002/9781118660485
Gaisser, S. and Nusser, M. (2010) Stellenwert der Biotechnologie in der pharmazeutischen Wirkstoffentwicklung. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen, 104, 732-737. https://doi.org/10.1016/j.zefq.2010.05.001
Neagu, M., Albulescu, R. and Tanase, C. (2015) Biotechnology Landscape in Cancer Drug Discovery. Future Science OA, 1, FSO12. https://doi.org/10.4155/fso.15.10
Kabadi, A., McDonnell, E., Frank, C.L. and Drowley, L. (2020) Applications of Functional Genomics for Drug Discovery. Sage Journals, 25, 823-842.
https://doi.org/10.1177/2472555220902092
Peter, H. (2015) How Genome Sequencing Is Aiding Drug Research and Development.
https://www.proclinical.com/blogs/2015-7/genome-sequencing-is-aiding-drug-research-and-development
Wang, L., McLeod, H.L. and Weinshilboum, R.M. (2011) Genomics and Drug Response. New England Journal of Medicine, 364, 1144-1153.
https://doi.org/10.1056/NEJMra1010600
Spreafico, R., Leah, B., Grossse, J., Virgin, H. and Telenti, A. (2020) Advances in Genomics for Drug Development. Genes, 11, 942.
https://doi.org/10.3390/genes11080942
Neha, S. and Harikumar, L. (2013) Use of Genomics and Proteomics in Pharmaceutical Drug Discovery and Development: A Review. International Journal of Pharmacy and Pharmaceutical Sciences, 5, 24-28.
Bumol, T.F. and Watanabe, A.M. (2001) Genetic Information, Genomic Technologies, and the Future of Drug Discovery. JAMA, 285, 551-555.
https://doi.org/10.1001/jama.285.5.551
Zhang, H.M., Nan, Z.R., Hui, G.Q., Liu, X.H. and Sun, Y. (2014) Application of Genomics and Proteomics in Drug Target Discovery. Genetics and Molecular Research: GMR, 13, 198-204. https://doi.org/10.4238/2014.January.10.11
Amiri-Dashatan, N., Koushki, M., Abbaszadeh, H.A., Rostami-Nejad, M. and Rezaei-Tavirani, M. (2018) Proteomics Applications in Health: Biomarker and Drug Discovery and Food Industry. Iranian Journal of Pharmaceutical Research: IJPR, 17, 1523.
Frantzi, M., Latosinska, A. and Mischak, H. (2019) Proteomics in Drug Development: The Dawn of a New Era? Proteomics-Clinical Applications, 13, Article ID: 1800087. https://doi.org/10.1002/prca.201800087
Jhanker, Y., Kadir, M., Khan, R. and Hasan, R. (2012) Proteomics in Drug Discovery, Journal of Applied Pharmaceutical Science, 2, 1-12.
https://doi.org/10.7324/JAPS.2012.2801
Hewick, R.M., Lu, Z. and Wang, J.H. (2003) Proteomics in Drug Discovery. In: Advances in Protein Chemistry, Vol. 65, Elsevier, Amsterdam, 309-342.
https://doi.org/10.1016/S0065-3233(03)01024-6
Walgran, J.L. and Thompson, D.C. (2004) Application of Proteomic Technologies in the Drug Development Process. Toxicology Letters, 149, 377-385.
https://doi.org/10.1016/j.toxlet.2003.12.047
Gromova, M., Vaggelas, A., Dallmann, G. and Seimetz, D. (2020) Biomarkers: Opportunities and Challenges for Drug Development in the Current Regulatory Landscape. Biomarker Insights, 15. https://doi.org/10.1177/1177271920974652
Schomaker, S., Ramaiah, S., Khan, N. and Burkhardt, J. (2019) Safety Biomarker Applications in Drug Development. The Journal of Toxicological Sciences, 44, 225-235. https://doi.org/10.2131/jts.44.225
McCarthy, M.I. and Hirschhorn, J.N. (2008) Genome-Wide Association Studies: Potential Next Steps on a Genetic Journey. Human Molecular Genetics, 17, R156-R165. https://doi.org/10.1093/hmg/ddn289
Altelaar, A.F., Munoz, J. and Heck, A.J. (2013) Next-Generation Proteomics: Towards an Integrative View of Proteome Dynamics. Nature Reviews Genetics, 14, 35-48. https://doi.org/10.1038/nrg3356
Aebersold, R. and Mann, M. (2016) Mass-Spectrometric Exploration of Proteome Structure and Function. Nature, 537, 347-355. https://doi.org/10.1038/nature19949
Aksu, B., Sezer, A.D., Yegen, G. and Kusçu, L. (2016) QbD Implementation in Biotechnological Product Development Studies. In: Chen, T.S. and Chai, S.C., Eds., Special Topics in Drug Discovery, IntechOpen, London, 133-155.
https://doi.org/10.5772/66296
Nayak, A.K., Ahmed, S.A., Beg, S., Tabish, M. and Hasnain, M.S. (2019) Application of Quality by Design for the Development of Biopharmaceuticals. In: Beg, S. and Hasnain, M.S., Eds., Pharmaceutical Quality by Design, Academic Press, Cambridge, 399-411. https://doi.org/10.1016/B978-0-12-815799-2.00019-8
Varu, R.K. and Khanna, A. (2010) Opportunities and Challenges to Implementing the Quality by Design Approach in Generic Drug Development. Journal of Generic Medicines, 7, 60-73. https://doi.org/10.1057/jgm.2009.37
Rathore, A.S. (2009) Roadmap for Implementation of Quality by Design (QbD) for Biotechnology Products. Trends in Biotechnology, 27, 546-553.
https://doi.org/10.1016/j.tibtech.2009.06.006
Tomba, E., Facco, P., Bezzo, F. and Barolo, M. (2013) Latent Variable Modeling to Assist the Implementation of Quality-by-Design Paradigms in Pharmaceutical Development and Manufacturing: A Review. International Journal of Pharmaceutics, 457, 283-297. https://doi.org/10.1016/j.ijpharm.2013.08.074
Yu, L.X. (2008) Pharmaceutical Quality by Design: Product and Process Development, Understanding, and Control. Pharmaceutical Research, 25, 781-791.
https://doi.org/10.1007/s11095-007-9511-1
Thompson, R.A., Isin, E.M., Li, Y., Weaver, R., Weidolf, L., Wilson, I. and Kenna, J.G. (2011) Risk Assessment and Mitigation Strategies for Reactive Metabolites in Drug Discovery and Development. Chemical-Biological Interactions, 192, 65-71.
https://doi.org/10.1016/j.cbi.2010.11.002
Zhang, X., Lionberger, R.A., Davit, B.M. and Yu, L.X. (2011) Utility of Physiologically Based Absorption Modeling in Implementing Quality by Design in Drug Development. The AAPS Journal, 13, 59-71.
https://doi.org/10.1208/s12248-010-9250-9
Hu, L., Fawcett, J.P. and Gu, J. (2012) Protein Target Discovery of Drug and Its Reactive Intermediate Metabolite by Using Proteomic Strategy. Acta Pharmaceutica Sinica B, 2, 126-136. https://doi.org/10.1016/j.apsb.2012.02.001
Zheng, J., Mehl, J., Zhu, Y., Xin, B. and Olah, T. (2014) Application and Challenges in Using LC-MS Assays for Absolute Quantitative Analysis of Therapeutic Proteins in Drug Discovery. Bioanalysis, 6, 859-879. https://doi.org/10.4155/bio.14.36
Daub, H., Godl, K., Brehmer, D., Klebl, B. and Müller, G. (2004) Evaluation of Kinase Inhibitor Selectivity by Chemical Proteomics. Assay and Drug Development Technologies, 2, 215-224. https://doi.org/10.1089/154065804323056558
Staker, B.L., Buchko, G.W. and Myler, P.J. (2015) Recent Contributions of Structure-Based Drug Design to the Development of Antibacterial Compounds. Current Opinion in Microbiology, 27, 133-138. https://doi.org/10.1016/j.mib.2015.09.003
Moellering, R.E. and Cravatt, B.F. (2012) How Chemoproteomics Can Enable Drug Discovery and Development. Chemistry & Biology, 19, 11-22.
https://doi.org/10.1016/j.chembiol.2012.01.001
Debouck, C. (2009) Integrating Genomics across Drug Discovery and Development. Toxicology Letters, 186, 9-12. https://doi.org/10.1016/j.toxlet.2008.09.011
Bahadduri, P.M., Polli, J.E., Swaan, P.W. and Ekins, S. (2010) Targeting Drug Transporters-Combining in Silico and in Vitro Approaches to Predict in Vivo. In: Yan, Q., Ed., Membrane Transporters in Drug Discovery and Development, Springer, Berlin, 65-103. https://doi.org/10.1007/978-1-60761-700-6_4
Gomez-Lechon, M.J., Lahoz, A., Gombau, L., Castell, J.V. and Donato, M.T. (2010) In Vitro Evaluation of Potential Hepatotoxicity Induced by Drugs. Current Pharmaceutical Design, 16, 1963-1977. https://doi.org/10.2174/138161210791208910
Vandana, U.K., Rajkumari, J., Singha, L.P., Satish, L., Alavilli, H., Sudheer, P.D. and Pandey, P. (2021) The Endophytic Microbiome as a Hotspot of Synergistic Interactions, with Prospects of Plant Growth Promotion. Biology, 10, Article No. 101.
https://doi.org/10.3390/biology10020101
Risueño, I., Valencia, L., Jorcano, J.L. and Velasco, D. (2021) Skin-on-a-Chip Models: General Overview and Future Perspectives. APL Bioengineering, 5, Article ID: 030901. https://doi.org/10.1063/5.0046376
Nirmalanandhan, V.S. and Sittampalam, G.S. (2009) Stem Cells in Drug Discovery, Tissue Engineering, and Regenerative Medicine: Emerging Opportunities and Challenges. Journal of Biomolecular Screening, 14, 755-768.
https://doi.org/10.1177/1087057109336591
Mimeault, M. and Batra, S.K. (2006) Concise Review: Recent Advances on the Significance of Stem Cells in Tissue Regeneration and Cancer Therapies. Stem Cells, 24, 2319-2345. https://doi.org/10.1634/stemcells.2006-0066
Keung, A.J., Kumar, S. and Schaffer, D.V. (2010) Presentation Counts: Microenvironmental Regulation of Stem Cells by Biophysical and Material Cues. Annual Review of Cell and Developmental Biology, 26, 533-556.
https://doi.org/10.1146/annurev-cellbio-100109-104042
Augello, A., Kurth, T.B. and De Bari, C. (2010) Mesenchymal Stem Cells: A Perspective from in Vitro Cultures to in Vivo Migration and Niches. European Cells and Materials, 20, e33. https://doi.org/10.22203/eCM.v020a11
Bassingthwaighte, J.B. and Vinnakota, K.C. (2004) The Computational Integrated Myocyte: A View into the Virtual Heart. Annals of the New York Academy of Sciences, 1015, 391-404. https://doi.org/10.1196/annals.1302.034
Wang, F.Y. and Wong, P.K. (2013) Intelligent Systems and Technology for Integrative and Predictive Medicine: An ACP Approach. ACM Transactions on Intelligent Systems and Technology (TIST), 4, 1-6. https://doi.org/10.1145/2438653.2438667
Li, S., Zhang, B. and Zhang, N. (2011) Network Target for Screening Synergistic Drug Combinations with Application to Traditional Chinese Medicine. BMC Systems Biology, 5, 1-13. https://doi.org/10.1186/1752-0509-5-S1-S10
Kuhn, M., Campillos, M., Letunic, I., Jensen, L.J. and Bork, P. (2010) A Side Effect Resource to Capture Phenotypic Effects of Drugs. Molecular Systems Biology, 6, 343. https://doi.org/10.1038/msb.2009.98
Ekins, S., Williams, A.J., Krasowski, M.D. and Freundlich, J.S. (2011) In Silico Repositioning of Approved Drugs for Rare and Neglected Diseases. Drug Discovery Today, 16, 298-310. https://doi.org/10.1016/j.drudis.2011.02.016
Mendrick, D.L. (2011) Transcriptional Profiling to Identify Biomarkers of Disease and Drug Response. Pharmacogenomics, 12, 235-249.
https://doi.org/10.2217/pgs.10.184
Mah, J.T., Low, E.S. and Lee, E. (2011) In Silico SNP Analysis and Bioinformatics Tools: A Review of the State of the Art to Aid Drug Discovery. Drug Discovery Today, 16, 800-809. https://doi.org/10.1016/j.drudis.2011.07.005
Liu, Y., Wang, L., Kikuiri, T., Akiyama, K., Chen, C., Xu, X. and Shi, S. (2020) Mesenchymal Stem Cell-Based Tissue Regeneration Is Governed by Recipient T Lymphocytes via IFN-γ and TNF-α. Nature Medicine, 24, 1434-1442.
Abaci, H.E., Shen, Y.I. and Wu, J.C. (2015) In Vivo Imaging of Embryonic Stem Cells Reveals Patterns of Survival and Immune Rejection Following Transplantation. Stem Cells and Development, 24, 321-330.
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K. and Yamanaka, S. (2007) Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors. Cell, 131, 861-872.
https://doi.org/10.1016/j.cell.2007.11.019
Walters, W.P. and Murcko, M.A. (2002) Prediction of “Drug-Likeness”. Advanced Drug Delivery Reviews, 54, 255-271.
https://doi.org/10.1016/S0169-409X(02)00003-0
Lavecchia, A. and Di Giovanni, C. (2013) Virtual Screening Strategies in Drug Discovery: A Critical Review. Current Medicinal Chemistry, 20, 2839-2860.
https://doi.org/10.2174/09298673113209990001
Cheng, F., Li, W., Wu, Z., Wang, X., Zhang, C., Li, J. and Tang, Y. (2013) Prediction of Polypharmacological Profiles of Drugs by the Integration of Chemical, Side Effect, and Therapeutic Space. Journal of Chemical Information and Modeling, 53, 753-762. https://doi.org/10.1021/ci400010x
Kitchen, D.B., Decornez, H., Furr, J.R. and Bajorath, J. (2004) Docking and Scoring in Virtual Screening for Drug Discovery: Methods and Applications. Nature Reviews Drug Discovery, 3, 935-949. https://doi.org/10.1038/nrd1549
Smith, A., Ammar, R., Nislow, C., Giaever, G. (2010) A Survey of Yeast Genomic Assays for Drug and Target Discovery. Pharmacology & Therapeutics, 127, 156-164. https://doi.org/10.1016/j.pharmthera.2010.04.012
Nermin, P.K., Murodzhon, A. and Murat, C. (2014) A Drug Similarity Network for Understanding Drug Mechanism of Action. Journal of Bioinformatics and Computational Biology, 12, Article ID: 1441007.
https://doi.org/10.1142/S0219720014410078
Yan, X., Liao, C., Liu, Z., Hagler, A.T., Gu, Q. and Xu, J. (2015) Chemical Structure Similarity Search for Ligand-Based Virtual Screening: Methods and Computational Resources. Current Drug Targets, 16, 1580-1585.
Maggiora, G., Vogt, M., Stumpfe, D. and Bajorath, J. (2014) Molecular Similarity in Medicinal Chemistry. Journal of Medicinal Chemistry, 57, 3186-3204.
https://doi.org/10.1021/jm401411z
Devinyak, O., Havrylyuk, D. and Lesyk, R. (2014) 3D-MoRSE Descriptors Explained. Journal of Molecular Graphics and Modelling, 54, 194-203.
https://doi.org/10.1016/j.jmgm.2014.10.006
Holzinger, A., Keiblinger, K., Holub, P., Zatloukal, K. and Müller, H. (2023) AI for Life: Trends in Artificial Intelligence for Biotechnology. New Biotechnology, 74, 16-24. https://doi.org/10.1016/j.nbt.2023.02.001
Suleiman, T.A., Tolulope, A.M., Wuraola, F.O., Olorunfemi, R., Kasali, W.A., Okorocha, B.O., Dirisu, C. and Njoku, P.C. (2023) Overview of Cancer Management—The Role of Medical Imaging and Machine Learning Techniques in Early Detection of Cancer: Prospects, Challenges, and Future Directions. Open Access Library Journal, 10, e10014. https://doi.org/10.4236/oalib.1110014
Gupta, R., Srivastava, D., Sahu, M., Tiwari, S., Ambasta, R.K. and Kumar, P. (2021) Artificial Intelligence to Deep Learning: Machine Intelligence Approach for Drug Discovery. Molecular Diversity, 25, 1315-1360.
https://doi.org/10.1007/s11030-021-10217-3
Saldívar-González, F.I., Aldas-Bulos, V.D., Medina-Franco, J.L. and Plisson, F. (2022) Natural Product Drug Discovery in the Artificial Intelligence Era. Chemical Science, 13, 1526-1546. https://doi.org/10.1039/D1SC04471K
Tripathi, A., Misra, K., Dhanuka, R. and Singh, J.P. (2022) Artificial Intelligence in Accelerating Drug Discovery and Development. Recent Patents on Biotechnology, 17, 9-23. https://doi.org/10.2174/1872208316666220802151129
